187 filings
S-8
JANX
Janux Therapeutics Inc
8 Mar 24
Registration of securities for employees
4:47pm
10-K
2023 FY
JANX
Janux Therapeutics Inc
Annual report
8 Mar 24
4:23pm
8-K
JANX
Janux Therapeutics Inc
8 Mar 24
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
4:11pm
SC 13D/A
JANX
Janux Therapeutics Inc
6 Mar 24
Janux Therapeutics / RA CAPITAL MANAGEMENT ownership change
6:54pm
4
RA Capital Nexus Fund II, L.P.
6 Mar 24
Janux Therapeutics / Rajeev M. Shah ownership change
4:15pm
SC 13D/A
JANX
Janux Therapeutics Inc
4 Mar 24
Janux Therapeutics / Avalon Ventures XI ownership change
8:07pm
4
Avalon BioVentures SPV I, L.P.
4 Mar 24
Change in insider ownership
7:31pm
4
Gujrathi Sheila
4 Mar 24
Janux Therapeutics / Sheila Gujrathi ownership change
4:44pm
4
Capps Vickie L
4 Mar 24
Janux Therapeutics / VICKIE L CAPPS ownership change
4:33pm
424B5
JANX
Janux Therapeutics Inc
29 Feb 24
Prospectus supplement for primary offering
5:30pm
8-K
JANX
Janux Therapeutics Inc
29 Feb 24
Janux Therapeutics Announces Proposed Public Offering of Common Stock
5:11pm
FWP
JANX
Janux Therapeutics Inc
28 Feb 24
Free writing prospectus
9:55pm
8-K
JANX
Janux Therapeutics Inc
28 Feb 24
Other Events
5:15pm
424B5
JANX
Janux Therapeutics Inc
27 Feb 24
Prospectus supplement for primary offering
9:50pm
8-K
JANX
Janux Therapeutics Inc
27 Feb 24
Other Events
5:23pm
8-K
JANX
Janux Therapeutics Inc
26 Feb 24
83% (5/6) of subjects achieved PSA50 declines with first step dose ≥ 0.2mg
4:23pm
SC 13G/A
JANX
Janux Therapeutics Inc
14 Feb 24
Janux Therapeutics / EcoR1 Capital ownership change
5:53pm
SC 13G/A
Citadel Advisors LLC
14 Feb 24
Janux Therapeutics / CITADEL ADVISORS ownership change
4:58pm
SC 13G/A
JANX
Janux Therapeutics Inc
14 Feb 24
Janux Therapeutics / BIOTECHNOLOGY VALUE FUND L P ownership change
9:43am
SC 13G/A
David Alan Campbell
9 Feb 24
Janux Therapeutics / Campbell David Alan ownership change
4:31pm